These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 14756718)

  • 21. Methadone-induced bradycardia.
    Ashwath ML; Ajjan M; Culclasure T
    J Emerg Med; 2005 Jul; 29(1):73-5. PubMed ID: 15961013
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Galactorrhoea may be associated with methadone use.
    Bennett J; Whale R
    BMJ; 2006 May; 332(7549):1071. PubMed ID: 16675813
    [No Abstract]   [Full Text] [Related]  

  • 23. Rhabdomyolysis with acute renal failure secondary to taking methadone.
    Valga-Amado F; Monzón-Vázquez TR; Hadad F; Torrente-Sierra J; Pérez-Flores I; Barrientos-Guzmán A
    Nefrologia; 2012; 32(2):262-3. PubMed ID: 22466280
    [No Abstract]   [Full Text] [Related]  

  • 24. (R)-methadone versus racemic methadone: what is best for patient care?
    McCance-Katz EF
    Addiction; 2011 Apr; 106(4):687-8. PubMed ID: 21371149
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparing overdose mortality associated with methadone and buprenorphine treatment.
    Bell JR; Butler B; Lawrance A; Batey R; Salmelainen P
    Drug Alcohol Depend; 2009 Sep; 104(1-2):73-7. PubMed ID: 19443138
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Long-term treatment with opioids and cognition disorders].
    Ege PP
    Ugeskr Laeger; 1994 Jan; 156(2):200. PubMed ID: 7905218
    [No Abstract]   [Full Text] [Related]  

  • 27. Prevalence of long QTc interval in methadone maintenance patients.
    Fonseca F; Marti-Almor J; Pastor A; Cladellas M; Farré M; de la Torre R; Torrens M
    Drug Alcohol Depend; 2009 Jan; 99(1-3):327-32. PubMed ID: 18774239
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Buprenorphine and methadone treatment of opiate dependence during pregnancy: comparison of fetal growth and neonatal outcomes in two consecutive case series.
    Kakko J; Heilig M; Sarman I
    Drug Alcohol Depend; 2008 Jul; 96(1-2):69-78. PubMed ID: 18355989
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Methadone- and buprenorphine-related ambulance attendances: a population-based indicator of adverse events.
    Nielsen S; Dietze P; Cantwell K; Lee N; Taylor D
    J Subst Abuse Treat; 2008 Dec; 35(4):457-61. PubMed ID: 18295435
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Concurrent buprenorphine and benzodiazepines use and self-reported opioid toxicity in opioid substitution treatment.
    Nielsen S; Dietze P; Lee N; Dunlop A; Taylor D
    Addiction; 2007 Apr; 102(4):616-22. PubMed ID: 17286641
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Depression in methadone maintenance treatment patients: rate and risk factors.
    Peles E; Schreiber S; Naumovsky Y; Adelson M
    J Affect Disord; 2007 Apr; 99(1-3):213-20. PubMed ID: 17055063
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Routine ECG in methadone-assisted rehabilitation is wrong prioritization].
    Krook AL; Waal H; Hansteen V
    Tidsskr Nor Laegeforen; 2004 Nov; 124(22):2940-1. PubMed ID: 15550974
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Is it time to reformulate racemic methadone?
    Karch SB
    J Addict Med; 2011 Sep; 5(3):229-31. PubMed ID: 21841431
    [No Abstract]   [Full Text] [Related]  

  • 34. Stercoral perforation of the colon. A complication of methadone maintenance.
    Haley TD; Long C; Mann BD
    J Subst Abuse Treat; 1998; 15(5):443-4. PubMed ID: 9751002
    [No Abstract]   [Full Text] [Related]  

  • 35. An epidemiological investigation into an outbreak of rash illness among methadone maintenance clients in Australia.
    McAnulty JM; Jauncey ME; Monger CK; Hailstone ST; Alam NK; Mannes TF; Capon AG; Irvine K; Armstrong PK; Kaldor JM
    Drug Alcohol Rev; 2007 May; 26(3):321-31. PubMed ID: 17454022
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Methadone and caries. Case reports.
    Sheedy JJ
    Aust Dent J; 1996 Dec; 41(6):367-9. PubMed ID: 9008991
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Slow-release oral morphine for maintenance treatment of opioid addicts intolerant to methadone or with inadequate withdrawal suppression.
    Kastelic A; Dubajic G; Strbad E
    Addiction; 2008 Nov; 103(11):1837-46. PubMed ID: 19032534
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of saquinavir/ritonavir (1000/100 mg bid) on the pharmacokinetics of methadone in opiate-dependent HIV-negative patients on stable methadone maintenance therapy.
    Jamois C; Smith P; Morrison R; Riek M; Patel A; Schmitt C; Morcos PN; Zhang X
    Addict Biol; 2009 Jul; 14(3):321-7. PubMed ID: 19523046
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Influence of peak and trough levels of opioid maintenance therapy on driving aptitude.
    Baewert A; Gombas W; Schindler SD; Peternell-Moelzer A; Eder H; Jagsch R; Fischer G
    Eur Addict Res; 2007; 13(3):127-35. PubMed ID: 17570908
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Monopoly of the methadone treatment].
    Haarr D
    Tidsskr Nor Laegeforen; 2004 Feb; 124(3):311. PubMed ID: 14963497
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.